BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/16/2014 3:53:00 PM | Browse: 1130 | Download: 1030
 |
Received |
|
2013-10-27 22:31 |
 |
Peer-Review Started |
|
2013-10-28 13:42 |
 |
To Make the First Decision |
|
2013-12-16 17:48 |
 |
Return for Revision |
|
2013-12-17 16:43 |
 |
Revised |
|
2014-01-11 15:20 |
 |
Second Decision |
|
2014-05-26 16:19 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-26 16:41 |
 |
Articles in Press |
|
2014-05-26 17:39 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-09-19 17:23 |
 |
Publish the Manuscript Online |
|
2014-10-16 15:53 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Molecular targeting to treat gastric cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Keishiro Aoyagi, Kikuo Kouhuji, Junya Kizaki, Taro Isobe, Kousuke Hashimoto and Kazuo Shirouzu |
Funding Agency and Grant Number |
|
Corresponding Author |
Keishiro Aoyagi, MD, PhD, Department of Surgery, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan. keishiro@med.kurume-u.ac.jp |
Key Words |
Gastric cancer; Molecular targeting therapy; human epidermal growth factor receptor 2 protein; vascular endothelial growth factors/Vascular endothelial growth factor receptor pathway; epidermal growth factors pathway |
Core Tip |
So far, trastuzumab is the only molecular targeting therapy that has been approved for treating gastric cancer. The significance of molecular targeting therapy for gastric cancer remains controversial, but large scale randomized clinical trials might confirm the benefits of other novel molecular targeting therapies for gastric cancer in the near future. |
Publish Date |
2014-10-16 15:53 |
Citation |
Aoyagi K, Kouhuji K, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting to treat gastric cancer. World J Gastroenterol 2014; 20(38): 13741-13755 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i38/13741.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i38.13741 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345